Platelets as immune mediators: Their role in host defense responses and sepsis

Thrombosis Research

Volumn 127, Issue 3, 2011, Pages 184-188

  Li, Zhenyu ^a   Yang, Fanmuyi ^a   Dunn, Steve ^b   Gross, A Kendall ^b   Smyth, Susan S ^a,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b University of Kentucky   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; CD40 LIGAND; CLOPIDOGREL; INTERLEUKIN 1BETA; LIPOPOLYSACCHARIDE; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; THROMBOCYTE ACTIVATING FACTOR; THROMBOCYTE FACTOR 4; TICLOPIDINE;

ACUTE LUNG INJURY; ADAPTIVE IMMUNITY; ATHEROSCLEROSIS; BLOOD VESSEL INJURY; CELL INTERACTION; CELL PROTECTION; ENTERITIS; FIBRIN DEPOSITION; GLOMERULONEPHRITIS; HOST RESISTANCE; HUMAN; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; LIVER INJURY; MALARIA; MEDIATOR RELEASE; MULTIPLE ORGAN FAILURE; NEUTROPHIL; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; REVIEW; SEPSIS; STAPHYLOCOCCUS AUREUS; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; THROMBOCYTE RELEASE REACTION; THROMBOCYTOPENIA; TISSUE INJURY; TREATMENT OUTCOME; VASCULITIS;

ANIMALS; BLOOD PLATELETS; HUMANS; SEPSIS;

EID: 79951945758     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.10.010     Document Type: Review

References (40)

1. Davi G, Patrono C. Platelet activation and atherothrombosis. N Engl J Med December 13 2007;357(24):2482-94.
2. Smyth SS, McEver RP, Weyrich AS, Morrell CN, Hoffman MR, Arepally GM, et al. Platelet functions beyond hemostasis. J Thromb Haemost November 2009;7(11):1759-66.
3. Senzel L, Gnatenko DV, Bahou WF. The platelet proteome. Curr Opin Hematol September 2009;16(5):329-33.
4. Antoniades C, Bakogiannis C, Tousoulis D, Antonopoulos AS, Stefanadis C. The CD40/CD40 ligand system: linking inflammation with atherothrombosis. J Am Coll Cardiol August 18 2009;54(8):669-77.
5. Cognasse F, Hamzeh-Cognasse H, Lafarge S, Chavarin P, Cogne M, Richard Y, et al. Human platelets can activate peripheral blood B cells and increase production of immunoglobulins. Exp Hematol September 2007;35(9):1376-87. (Pubitemid 47302591)
6. van Gils JM, Zwaginga JJ, Hordijk PL. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol February 2009;85(2):195-204.
7. Mazzarello P, Calligaro AL, Calligaro A. Giulio Bizzozero: a pioneer of cell biology. Nat Rev Mol Cell Biol October 2001;2(10):776-81.
8. Palabrica T, Lobb R, Furie BC, Aronovitz M, Benjamin C, Hsu YM, et al. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature October 29 1992;359(6398):848-51.
9. Steinhubl SR, Badimon JJ, Bhatt DL, Herbert JM, Luscher TF. Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease. Vasc Med May 2007;12(2):113-22. (Pubitemid 46995474)
10. Evangelista V, Manarini S, Dell'Elba G, Martelli N, Napoleone E, Di SA, et al. Clopidogrel inhibits platelet-leukocyte adhesion and platelet-dependent leukocyte activation. Thromb Haemost September 2005;94(3):568-77. (Pubitemid 41300854)
11. Waehre T, Damas JK, Pedersen TM, Gullestad L, Yndestad A, Andreassen AK, et al. Clopidogrel increases expression of chemokines in peripheral blood mononuclear cells in patients with coronary artery disease: results of a double-blind placebocontrolled study. J Thromb Haemost October 2006;4(10):2140-7. (Pubitemid 44400287)
12. Fitzgerald JR, Foster TJ, Cox D. The interaction of bacterial pathogens with platelets. Nat Rev Microbiol June 2006;4(6):445-57. (Pubitemid 43771864)
13. Loughman A, Fitzgerald JR, Brennan MP, Higgins J, Downer R, Cox D, et al. Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A. Mol Microbiol August 2005;57(3):804-18. (Pubitemid 41025961)
14. Youssefian T, Drouin A, Masse JM, Guichard J, Cramer EM. Host defense role of platelets: engulfment of HIV and Staphylococcus aureus occurs in a specific subcellular compartment and is enhanced by platelet activation. Blood June 1 2002;99(11):4021-9. (Pubitemid 35332043)
15. Andonegui G, Kerfoot SM, McNagny K, Ebbert KV, Patel KD, Kubes P. Platelets express functional Toll-like receptor-4. Blood October 1 2005;106(7):2417-23. (Pubitemid 41510815)
16. Zhang G, Han J, Welch EJ, Ye RD, Voyno-Yasenetskaya TA, Malik AB, et al. Lipopolysaccharide stimulates platelet secretion and potentiates platelet aggregation via TLR4/MyD88 and the cGMP-dependent protein kinase pathway. J Immunol June 15 2009;182(12):7997-8004.
17. Cognasse F, Lafarge S, Chavarin P, Acquart S, Garraud O. Lipopolysaccharide induces sCD40L release through human platelets TLR4, but not TLR2 and TLR9. Intensive Care Med February 2007;33(2):382-4. (Pubitemid 46221256)
18. Cognasse F, Hamzeh-Cognasse H, Lafarge S, Delezay O, Pozzetto B, McNicol A, et al. Toll-like receptor 4 ligand can differentially modulate the release of cytokines by human platelets. Br J Haematol April 2008;141(1):84-91. (Pubitemid 351347530)
19. Stahl AL, Svensson M, Morgelin M, Svanborg C, Tarr PI, Mooney JC, et al. Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood July 1 2006;108(1):167-76. (Pubitemid 43990625)
20. Ward JR, Bingle L, Judge HM, Brown SB, Storey RF, Whyte MK, et al. Agonists of toll-like receptor (TLR)2 and TLR4 are unable to modulate platelet activation by adenosine diphosphate and platelet activating factor. Thromb Haemost October 2005;94(4):831-8. (Pubitemid 41489246)
21. Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med April 2007;13(4):463-9. (Pubitemid 46559832)
22. Ma AC, Kubes P. Platelets, neutrophils, and neutrophil extracellular traps (NETs) in sepsis. J Thromb Haemost March 2008;6(3):415-20. (Pubitemid 351280107)
23. McMorran BJ, Marshall VM, de GC, Drysdale KE, Shabbar M, Smyth GK, et al. Platelets kill intraerythrocytic malarial parasites and mediate survival to infection. Science February 6 2009;323(5915):797-800.
24. Baughman RP, Lower EE, Flessa HC, Tollerud DJ. Thrombocytopenia in the intensive care unit. Chest October 1993;104(4):1243-7. (Pubitemid 23306086)
25. Stephan F, Hollande J, Richard O, Cheffi A, Maier-Redelsperger M, Flahault A. Thrombocytopenia in a surgical ICU. Chest May 1999;115(5):1363-70. (Pubitemid 29230648)
26. Moreau D, Timsit JF, Vesin A, Garrouste-Org, de LA, Zahar JR, Adrie C, et al. Platelet count decline: an early prognostic marker in critically ill patients with prolonged ICU stays. Chest June 2007;131(6):1735-41. (Pubitemid 46981627)
27. Nachman RL, Rafii S. Platelets, petechiae, and preservation of the vascular wall. N Engl J Med September 18 2008;359(12):1261-70.
28. Zhao L, Ohtaki Y, Yamaguchi K, Matsushita M, Fujita T, Yokochi T, et al. LPSinduced platelet response and rapid shock in mice: contribution of O-antigen region of LPS and involvement of the lectin pathway of the complement system. Blood November 1 2002;100(9):3233-9. (Pubitemid 35217072)
29. Zarbock A, Ley K. The role of platelets in acute lung injury (ALI). Front Biosci 2009;14:150-8.
30. Aslam R, Speck ER, Kim M, Crow AR, Bang KW, Nestel FP, et al. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood January 15 2006;107(2):637-41. (Pubitemid 43076388)
31. Jayachandran M, Brunn GJ, Karnicki K, Miller RS, Owen WG, Miller VM. In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: implications for thrombotic risk. J Appl Physiol January 2007;102(1):429-33.
32. Winning J, Reichel J, Eisenhut Y, Hamacher J, Kohl M, Deigner HP, et al. Antiplatelet drugs and outcome in severe infection: clinical impact and underlying mechanisms. Platelets February 2009;20(1):50-7.
33. Seidel M, Winning J, Claus RA, Bauer M, Losche W. Beneficial effect of clopidogrel in a mouse model of polymicrobial sepsis. J Thromb Haemost June 2009;7(6):1030-2.
34. Lipcsey M, Larsson A, Olovsson M, Sjolin J, Eriksson MB. Early endotoxin-mediated haemostatic and inflammatory responses in the clopidogrel-treated pig. Platelets November 2005;16(7):408-14. (Pubitemid 41564338)
35. Pu Q, Wiel E, Corseaux D, Bordet R, Azrin MA, Ezekowitz MD, et al. Beneficial effect of glycoprotein IIb/IIIa inhibitor (AZ-1) on endothelium in Escherichia coli endotoxin-induced shock. Crit Care Med June 2001;29(6):1181-8. (Pubitemid 32554332)
36. Taylor FB, Coller BS, Chang AC, Peer G, Jordan R, Engellener W, et al. 7E3 F(ab')2, a monoclonal antibody to the platelet GPIIb/IIIa receptor, protects against microangiopathic hemolytic anemia and microvascular thrombotic renal failure in baboons treated with C4b binding protein and a sublethal infusion of Escherichia coli. Blood June 1 1997;89(11):4078-84.
37. Winning J, Neumann J, Kohl M, Claus RA, Reinhart K, Bauer M, et al. Antiplatelet drugs and outcome in mixed admissions to an intensive care unit. Crit Care Med January 2010;38(1):32-7.
38. Erlich JM, Talmor DS, Cartin-Ceba R, Gajic O, Kor DJ. Pre-hospitalization antiplatelet therapy is associated with a reduced incidence of acute lung injury: A population-based cohort study. Chest August 5 2010.
39. A.K. Gross, S.P. Dun, D.J. Feola, C.A. Martin, S.S. Smyth, in press. Effect of clopidogrel therapy on the incidence and severity of community acquired pneumonia: results of a five year cohort. Circulation 2010;abs.
40. Blasco-Colmenares E, Perl TM, Guallar E, Baumgartner WA, Conte JV, Alejo D, et al. Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery. Arch Intern Med April 27 2009;169(8):788-96.